At least a dozen experimental weight-loss drugs designed to be taken as pills are working their way through clinical trials, with the most advanced now in the third and final stage of testing.

"Weight loss medications are not one size fits all and patients should always discuss options with a trusted medical professional," one expert told Newsweek.

Many people are doing an end-run around their doctor's office, reaching out to potentially unreliable sources that promise to set them up with Wegovy, Zepbound and other weight-loss drugs.

In July, the U.S. Food and Drug Administration warned that people are overdosing on compounded semaglutide injectable products.

As GLP-1 weight loss drugs fly off shelves, Kourtney Kardashian Barker is getting in on the hustle — well, sort of. As Business Insider and other outlets report, Kardashian Barker's brand Lemme has launched a new line of oral supplements marketed as an alternative to actual glucagon-like peptide-1 drugs like Ozempic and Wegovy.